DK160269C - Analogifremgangsmaade til fremstilling af 4-aroyl-1,3-dihydro-2h-imidazol-2-oner eller et farmaceutisk acceptabelt metalsalt eller basisk ammoniumsalt deraf - Google Patents

Analogifremgangsmaade til fremstilling af 4-aroyl-1,3-dihydro-2h-imidazol-2-oner eller et farmaceutisk acceptabelt metalsalt eller basisk ammoniumsalt deraf

Info

Publication number
DK160269C
DK160269C DK259080A DK259080A DK160269C DK 160269 C DK160269 C DK 160269C DK 259080 A DK259080 A DK 259080A DK 259080 A DK259080 A DK 259080A DK 160269 C DK160269 C DK 160269C
Authority
DK
Denmark
Prior art keywords
oner
aroyl
imidazol
dihydro
analogue
Prior art date
Application number
DK259080A
Other languages
Danish (da)
English (en)
Other versions
DK259080A (da
DK160269B (da
Inventor
Richard A Schnettler
Richard C Dage
J Martin Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK160269(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of DK259080A publication Critical patent/DK259080A/da
Publication of DK160269B publication Critical patent/DK160269B/da
Application granted granted Critical
Publication of DK160269C publication Critical patent/DK160269C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK259080A 1979-06-18 1980-06-17 Analogifremgangsmaade til fremstilling af 4-aroyl-1,3-dihydro-2h-imidazol-2-oner eller et farmaceutisk acceptabelt metalsalt eller basisk ammoniumsalt deraf DK160269C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US4980879 1979-06-18
US11920780A 1980-02-07 1980-02-07
US11920780 1980-02-07

Publications (3)

Publication Number Publication Date
DK259080A DK259080A (da) 1980-12-19
DK160269B DK160269B (da) 1991-02-18
DK160269C true DK160269C (da) 1991-07-22

Family

ID=26727558

Family Applications (1)

Application Number Title Priority Date Filing Date
DK259080A DK160269C (da) 1979-06-18 1980-06-17 Analogifremgangsmaade til fremstilling af 4-aroyl-1,3-dihydro-2h-imidazol-2-oner eller et farmaceutisk acceptabelt metalsalt eller basisk ammoniumsalt deraf

Country Status (20)

Country Link
AT (1) AT375349B (enExample)
AU (1) AU532783B2 (enExample)
CA (1) CA1132554A (enExample)
CH (1) CH646155A5 (enExample)
DE (1) DE3021792A1 (enExample)
DK (1) DK160269C (enExample)
ES (1) ES492255A0 (enExample)
FR (1) FR2459233A1 (enExample)
GB (1) GB2055364B (enExample)
HK (1) HK61486A (enExample)
HU (1) HU186736B (enExample)
IE (1) IE50646B1 (enExample)
IL (1) IL60243A (enExample)
IT (1) IT1143922B (enExample)
MY (1) MY8600709A (enExample)
NL (2) NL193752C (enExample)
NO (1) NO152841C (enExample)
NZ (1) NZ193935A (enExample)
PH (1) PH18683A (enExample)
SE (2) SE447107B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
ZA822990B (en) * 1981-05-04 1983-03-30 Merrell Dow Pharma 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4329470A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4367236A (en) 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2007530566A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｒ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
EP1737448A1 (en) * 2004-03-22 2007-01-03 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
CA2920856C (en) 2013-08-09 2026-03-03 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
NO152841C (no) 1985-11-27
IL60243A0 (en) 1980-09-16
GB2055364A (en) 1981-03-04
NL193752B (nl) 2000-05-01
IE50646B1 (en) 1986-06-11
SE8004253L (sv) 1980-12-19
NL300015I1 (nl) 2000-11-01
CA1132554A (en) 1982-09-28
SE447107B (sv) 1986-10-27
MY8600709A (en) 1986-12-31
SE464559B (sv) 1991-05-13
IE801162L (en) 1980-12-18
PH18683A (en) 1985-08-29
NO801796L (no) 1980-12-19
ATA314280A (de) 1983-12-15
DK259080A (da) 1980-12-19
CH646155A5 (de) 1984-11-15
NL193752C (nl) 2000-09-04
DE3021792C2 (enExample) 1989-08-10
DK160269B (da) 1991-02-18
SE8501452D0 (sv) 1985-03-25
IT8048997A0 (it) 1980-06-17
NO152841B (no) 1985-08-19
HK61486A (en) 1986-08-29
AT375349B (de) 1984-07-25
ES8105299A1 (es) 1981-06-01
AU532783B2 (en) 1983-10-13
SE8501452L (sv) 1985-03-25
ES492255A0 (es) 1981-06-01
GB2055364B (en) 1983-06-08
NZ193935A (en) 1985-05-31
NL8003498A (nl) 1980-12-22
IT1143922B (it) 1986-10-29
HU186736B (en) 1985-09-30
NL300015I2 (nl) 2000-10-02
AU5911880A (en) 1981-01-08
FR2459233A1 (fr) 1981-01-09
IL60243A (en) 1987-01-30
DE3021792A1 (de) 1981-01-22
FR2459233B1 (enExample) 1983-09-23

Similar Documents

Publication Publication Date Title
DK149308C (da) Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK155048C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinforbindelser
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK156825C (da) Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf
DK148477C (da) Analogifremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK145260C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK148904C (da) Analogifremgangsmaade til fremstilling af analgetisk virksomme enkephalin-analoge pentapeptidamider eller farmaceutisk acceptable, ikke-toxiske syreadditionssalte deraf
DK160045C (da) Analogifremgangsmaade til fremstilling af 4-oxo-4h-pyridooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere ammoniumsalte deraf
DK149846C (da) Analogifremgangsmaade til fremstilling af n,n'-bis-tetrahydro-isoquinolyldisulfonylimider
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK149231C (da) Analogifremgangsmaade til fremstilling af enkephalin-analoge tetrapeptidamider eller syreadditionssalte deraf
DK152677C (da) Analogifremgangsmaade til fremstilling af 4'-0-tetra-hydropyranyladriamycin eller et ugiftigt syreadditionssalt deraf
DK146281C (da) Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK149611C (da) Analogifremgangsmaade til fremstilling af trh-analoge tripeptidamider eller terapeutisk acceptable komplexer eller salte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK149625C (da) Analogifremgangsmaade til fremstilling af n-substituerede (8-halogen- eller -trifluormethyl-4-quinolylamino)-benzamider eller et farmaceutiskacceptabelt syreadditionssalt deraf
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK152427C (da) Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK160875C (da) Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PUP Patent expired